- Home
- BMRN vs COKE Comparison
BMRN vs COKE Comparison
Compare BMRN & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- COKE
- Stock Information
- Founded
- BMRN 1996
- COKE 1902
- Country
- BMRN United States
- COKE United States
- Employees
- BMRN N/A
- COKE N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- COKE Beverages (Production/Distribution)
- Sector
- BMRN Health Care
- COKE Consumer Staples
- Exchange
- BMRN Nasdaq
- COKE Nasdaq
- Market Cap
- BMRN 10.5B
- COKE 10.0B
- IPO Year
- BMRN 1999
- COKE N/A
- Fundamental
- Price
- BMRN $54.29
- COKE $161.92
- Analyst Decision
- BMRN Buy
- COKE
- Analyst Count
- BMRN 19
- COKE 0
- Target Price
- BMRN $90.26
- COKE N/A
- AVG Volume (30 Days)
- BMRN 2.8M
- COKE 476.6K
- Earning Date
- BMRN 10-27-2025
- COKE 10-29-2025
- Dividend Yield
- BMRN N/A
- COKE 0.62%
- EPS Growth
- BMRN 59.53
- COKE 22.14
- EPS
- BMRN 2.68
- COKE 7.03
- Revenue
- BMRN $3,094,001,000.00
- COKE $7,070,308,000.00
- Revenue This Year
- BMRN $13.32
- COKE N/A
- Revenue Next Year
- BMRN $7.51
- COKE N/A
- P/E Ratio
- BMRN $20.20
- COKE $22.71
- Revenue Growth
- BMRN 12.39
- COKE 4.22
- 52 Week Low
- BMRN $50.76
- COKE $105.21
- 52 Week High
- BMRN $73.51
- COKE $162.65
- Technical
- Relative Strength Index (RSI)
- BMRN 53.35
- COKE 83.96
- Support Level
- BMRN $53.67
- COKE $157.11
- Resistance Level
- BMRN $55.34
- COKE $162.43
- Average True Range (ATR)
- BMRN 1.49
- COKE 5.08
- MACD
- BMRN 0.28
- COKE 2.50
- Stochastic Oscillator
- BMRN 78.60
- COKE 97.05
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.